
Acteria Femina2.3 Billio
Radiant Pharmaceuticals Ltd.
Probiotic Combination [2.3 Billion] is a multi-strain probiotic dietary supplement providing a combinedcount of approximately 2.3 billion colony-forming units (CFU) of live beneficial bacteria per…
Probiotic Combination [2.3 Billion] is a multi-strain probiotic dietary supplement providing a combinedcount of approximately 2.3 billion colony-forming units (CFU) of live beneficial bacteria per dose.It is used to support gut microbiota balance and general digestive health.
Evidence for benefit is strain-specific; effects seen with one probiotic strain or combination cannotbe assumed to apply to another. Probiotic Combination [2.3 Billion] is a supplement, not a substitute for prescribed medical treatmentof any diagnosed condition.
| Population / Use | Typical Dose | Notes |
|---|---|---|
| Adults - general digestive health maintenance | 1 capsule/sachet (approx. 2.3 billion CFU) once daily, or as directed on the product label | May be taken with or without food, generally with a meal for consistency |
| Adults - adjunct during antibiotic therapy | 1 capsule/sachet once or twice daily | Separate dosing from the antibiotic by at least 2 hours (see Interactions) |
| Children (as per product labelling / physician advice) | Lower/weight-adjusted dose as specified on the product label | Use only the paediatric-labelled formulation and dose; consult a physician for infants |
Exact dosing should always follow the specific product label of Probiotic Combination [2.3 Billion] or the advice of a physician orpharmacist, as CFU count per unit and recommended frequency can vary between manufacturers.
Probiotic Combination [2.3 Billion] is generally well tolerated. Reported side effects include:
Discontinue Probiotic Combination [2.3 Billion] and seek medical advice if fever, signs of infection, or persistent/worseninggastrointestinal symptoms develop.
Probiotic Combination [2.3 Billion] is contraindicated in individuals with known hypersensitivity to any component of theformulation (including the specific bacterial strains or excipients used). Probiotic Combination [2.3 Billion] should not be usedin patients who are critically ill, have severe immunocompromise, or havean indwelling central venous catheter, because of a rare but reported risk of probiotic-relatedbacteraemia/fungaemia and systemic infection in these populations; use in such patients should only occurunder direct physician supervision where the potential benefit is judged to outweigh this risk.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.